Literature DB >> 8883142

Normal and leukemic human stem cells assayed in SCID mice.

J E Dick1.   

Abstract

Understanding the processes that regulate the developmental program of normal stem cells and those that initiate proliferative diseases such as leukemia remains one of the major challenges in biology. Progress to address these major questions in the human hematopoietic system have been hampered, until recently, by the lack of in-vivo assays for normal and leukemic stem cells. The recent development of methods to transplant normal and leukemic human hematopoietic cells into immune-deficient mice provides an important approach to identify, characterize and purify stem cells. This review will focus on the development of assays for normal and leukemic human stem cells and on the new insights these assays are beginning to provide on the organization of the human stem cell hierarchy and mechanisms of leukemogenesis.

Entities:  

Mesh:

Year:  1996        PMID: 8883142     DOI: 10.1006/smim.1996.0025

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  28 in total

Review 1.  Biological consequences of the BCR/ABL fusion gene in humans and mice.

Authors:  M Y Gordon
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

2.  Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.

Authors:  E Conneally; J Cashman; A Petzer; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 3.  [Tumor stem cell research - basis and challenge for diagnosis and therapy].

Authors:  Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2010-07-22       Impact factor: 1.704

4.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

5.  One-Year Observation of the SCID-Repopulating Cell Activities of Human Cord Blood-Derived CD34-Positive and -Negative Hematopoietic Stem Cells.

Authors:  Yoshikazu Matsuoka; Keisuke Sumide; Yoshiaki Sonoda
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

6.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

Authors:  M Bhatia; J C Wang; U Kapp; D Bonnet; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

7.  CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia.

Authors:  Ying-Ping Jiang; Bob Y Liu; Quan Zheng; Swapna Panuganti; Ruoying Chen; Jianyu Zhu; Madhavi Mishra; Jianqing Huang; Trang Dao-Pick; Sharmili Roy; XiaoXian Zhao; Jeffrey Lin; Gautam Banik; Eric D Hsi; Ramkumar Mandalam; Jagath R Junutula
Journal:  Blood Adv       Date:  2018-07-24

8.  Expansion of human SCID-repopulating cells under hypoxic conditions.

Authors:  Guénahel H Danet; Yi Pan; Jennifer L Luongo; Dominique A Bonnet; M Celeste Simon
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  C1qRp defines a new human stem cell population with hematopoietic and hepatic potential.

Authors:  Guenahel H Danet; Jennifer L Luongo; Gary Butler; Min Min Lu; Andrea J Tenner; M Celeste Simon; Dominique A Bonnet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-24       Impact factor: 11.205

10.  In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.

Authors:  Giovanni Amabile; Robert S Welner; Cesar Nombela-Arrieta; Anna Morena D'Alise; Annalisa Di Ruscio; Alexander K Ebralidze; Yevgenya Kraytsberg; Min Ye; Olivier Kocher; Donna S Neuberg; Konstantin Khrapko; Leslie E Silberstein; Daniel G Tenen
Journal:  Blood       Date:  2012-12-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.